Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akebia Therapeutics Inc (NASDAQ:AKBA)

14.96
Delayed Data
As of Aug 21
 -0.03 / -0.20%
Today’s Change
7.16
Today|||52-Week Range
16.54
+43.71%
Year-to-Date

Today’s Trading

Previous close14.99
Today’s open15.00
Day’s range14.70 - 15.14
Volume205,071
Average volume (3 months)794,199
Market cap$706.8M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)-57.21%
Earnings growth (this year)+12.90%
Earnings growth (next 5 years)+15.80%
Revenue growth (last year)--
P/E ratioNM
Price/Sales255.79
Price/Book8.50

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+1.60+1.64%
FLXNFlexion Therapeutics...+0.32+1.45%
ZIOPZIOPHARM Oncology In...+0.05+1.00%
AMPHAmphastar Pharmaceut...-0.15-0.99%
Data as of 08/21/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.7M
Net profit margin-8,843.45%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Director
John P. Butler
CFO, Treasure, SVP &
Principal Accounting Officer
Jason A. Amello
Corporate headquarters
Cambridge, Massachusetts

Forecasts